Tania Kuempfel

2.4k total citations
18 papers, 575 citations indexed

About

Tania Kuempfel is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Tania Kuempfel has authored 18 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 6 papers in Immunology and 5 papers in Neurology. Recurrent topics in Tania Kuempfel's work include Multiple Sclerosis Research Studies (11 papers), Peripheral Neuropathies and Disorders (3 papers) and Reproductive System and Pregnancy (3 papers). Tania Kuempfel is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Peripheral Neuropathies and Disorders (3 papers) and Reproductive System and Pregnancy (3 papers). Tania Kuempfel collaborates with scholars based in Germany, Slovakia and United States. Tania Kuempfel's co-authors include Joachim Havla, Hannah Pellkofer, Reinhard Hohlfeld, Markus Krumbholz, Edgar Meinl, Robert A. Bittner, Achim Berthele, Bernhard Hemmer, Michel Canis and Lisa Ann Gerdes and has published in prestigious journals such as PLoS ONE, Neurology and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Tania Kuempfel

17 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tania Kuempfel Germany 10 406 352 136 128 50 18 575
N. Téllez Spain 10 489 1.2× 261 0.7× 82 0.6× 153 1.2× 44 0.9× 19 561
Vanessa Daccach Marques Brazil 14 330 0.8× 263 0.7× 58 0.4× 87 0.7× 96 1.9× 32 522
Jessica Sagen United States 7 548 1.3× 578 1.6× 77 0.6× 200 1.6× 89 1.8× 13 790
Theodora A. M. Siepman Netherlands 14 402 1.0× 166 0.5× 205 1.5× 94 0.7× 76 1.5× 18 658
Reinhard Reuß Germany 9 422 1.0× 337 1.0× 73 0.5× 151 1.2× 88 1.8× 14 573
Chiara Costanzi United States 6 452 1.1× 407 1.2× 52 0.4× 139 1.1× 77 1.5× 7 511
Sei Hayakawa Japan 10 588 1.4× 461 1.3× 163 1.2× 190 1.5× 112 2.2× 14 751
Silvia Messina United Kingdom 12 507 1.2× 370 1.1× 47 0.3× 155 1.2× 59 1.2× 23 569
Jens Harmel Germany 9 385 0.9× 258 0.7× 75 0.6× 140 1.1× 76 1.5× 15 629
Roos M. van der Vuurst de Vries Netherlands 10 321 0.8× 140 0.4× 152 1.1× 74 0.6× 63 1.3× 14 493

Countries citing papers authored by Tania Kuempfel

Since Specialization
Citations

This map shows the geographic impact of Tania Kuempfel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tania Kuempfel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tania Kuempfel more than expected).

Fields of papers citing papers by Tania Kuempfel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tania Kuempfel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tania Kuempfel. The network helps show where Tania Kuempfel may publish in the future.

Co-authorship network of co-authors of Tania Kuempfel

This figure shows the co-authorship network connecting the top 25 collaborators of Tania Kuempfel. A scholar is included among the top collaborators of Tania Kuempfel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tania Kuempfel. Tania Kuempfel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kuempfel, Tania, et al.. (2023). NMOSD IgG Impact Retinal Cells in Murine Retinal Explants. Current Issues in Molecular Biology. 45(9). 7319–7335. 1 indexed citations
2.
Kuempfel, Tania, Sandra Thiel, Ingrid Meinl, et al.. (2019). Anti CD20 Therapies and Pregnancy in Neuroimmunological Disorders – A Case Series from Germany (P4.2-094). Neurology. 92(15_supplement). 2 indexed citations
3.
Oertel, Frederike Cosima, Joachim Havla, Adriana Roca‐Fernández, et al.. (2018). Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study. MDC Repository (Max-Delbrueck-Center for Molecular Medicine). 14 indexed citations
4.
Oertel, Frederike Cosima, Joachim Havla, Adriana Roca‐Fernández, et al.. (2018). Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study. Journal of Neurology Neurosurgery & Psychiatry. 89(12). 1259–1265. 82 indexed citations
5.
Hellwig, Kerstin, Sandra Thiel, Ingrid Meinl, Ralf Gold, & Tania Kuempfel. (2017). Long-term exposure to natalizumab during pregnancy – a prospective case series from the German Multiple Sclerosis and Pregnancy Registry (P2.101). Neurology. 88(16_supplement). 2 indexed citations
6.
Ayache, Samar S., Moussa A. Chalah, Tania Kuempfel, et al.. (2017). Emotionserkennung, Theory of Mind und Empathie bei Multipler Sklerose. Fortschritte der Neurologie · Psychiatrie. 85(11). 663–674. 3 indexed citations
8.
Haghikia, Aiden, Henriette Schneider, Tobias Tenenbaum, et al.. (2013). Natalizumb in Active MS during Pregnancy: Efficacy, Safety, and the Consequences for Foetal Haematopoiesis (P02.125). Neurology. 80(7_supplement). 1 indexed citations
9.
Pellkofer, Hannah, Joachim Havla, Daniela Hauer, et al.. (2013). The Major Brain Endocannabinoid 2-AG Controls Neuropathic Pain and Mechanical Hyperalgesia in Patients with Neuromyelitis Optica. PLoS ONE. 8(8). e71500–e71500. 39 indexed citations
10.
Havla, Joachim, Ingo Kleiter, & Tania Kuempfel. (2013). Bridging, switching or drug holidays – how to treat a patient who stops natalizumab?. Therapeutics and Clinical Risk Management. 9. 361–361. 27 indexed citations
11.
Ringelstein, Marius, Jens Harmel, Felix Distelmaier, et al.. (2013). Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum. Multiple Sclerosis Journal. 19(11). 1544–1547. 42 indexed citations
12.
Trebst, Corinna, Achim Berthele, Sven Jarius, et al.. (2011). Diagnostik und Therapie der Neuromyelitis optica:Konsensusempfehlungen der Neuromyelitis optica Studiengruppe [Diagnosis and treatment of neuromyelitis optica: Consensus recommendations of the Neuromyelitis Optica Study Group].
13.
Pellkofer, Hannah, Markus Krumbholz, Achim Berthele, et al.. (2011). Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab. Neurology. 76(15). 1310–1315. 232 indexed citations
14.
Pellkofer, Hannah, Raymond Voltz, & Tania Kuempfel. (2009). Favorable response to rituximab in a patient with anti‐VGCC‐positive Lambert‐Eaton myasthenic syndrome and cerebellar dysfunction. Muscle & Nerve. 40(2). 305–308. 27 indexed citations
15.
Schulze, Anja, et al.. (2009). Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab. Multiple Sclerosis Journal. 15(8). 1006–1008. 44 indexed citations
16.
Hoffmann, Lisa, Markus Krumbholz, Hans von Faber, et al.. (2007). Multiple sclerosis: Relating MxA transcription to anti-interferon-β-neutralizing antibodies. Neurology. 68(12). 958–959. 7 indexed citations
17.
Frieß, Elisabeth, Tania Kuempfel, S. Modell, et al.. (2006). Paroxetine treatment improves motor symptoms in patients with multiple system atrophy. Parkinsonism & Related Disorders. 12(7). 432–437. 31 indexed citations
18.
Frieß, Elisabeth, Tania Kuempfel, Juliane Winkelmann, et al.. (2001). Increased Growth Hormone Response to Apomorphine in Parkinson Disease Compared With Multiple System Atrophy. Archives of Neurology. 58(2). 241–241. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026